Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Hypoxia-inducible factor-1α (HIF-1α)
100%
Glycolysis
100%
Hepatocellular Carcinoma Cells
100%
USP29
100%
Sorafenib Resistance
100%
Aerobic Glycolysis
44%
Hepatocellular Carcinoma
33%
Sorafenib
33%
Transcriptional Activity
22%
Deubiquitinase
22%
Sorafenib-resistant Hepatocellular Carcinoma
22%
Hexokinase 2
22%
Current Therapies
11%
Unmet Medical Need
11%
Expression Level
11%
In Cancer
11%
Mouse Model
11%
Resistance to Therapy
11%
Transcriptional Targets
11%
Glycolytic Pathway
11%
Autologous Transplantation
11%
Aberrant Expression
11%
Glycolytic Metabolism
11%
Ubiquitin-specific Peptidase
11%
Multikinase Inhibitor
11%
Evasive Resistance
11%
Gene Encoding
11%
Hepatocellular Carcinoma Patient
11%
Medicine and Dentistry
Hypoxia Inducible Factor 1
100%
Hepatocellular Carcinoma
100%
Carcinoma Cell
100%
Glycolysis
100%
Sorafenib
100%
Aerobic Glycolysis
44%
Hexokinase
22%
Malignant Neoplasm
11%
In Vitro
11%
Xenograft
11%
Phosphotransferase Inhibitor
11%
Enzymes
11%
Peptidase
11%
Ubiquitin
11%
Biochemistry, Genetics and Molecular Biology
Glycolysis
100%
Hypoxia Inducible Factor 1
100%
Sorafenib
100%
Aerobic Glycolysis
44%
Hexokinase
22%
Metabolic Pathway
11%
Mouse Model
11%
Enzyme
11%
Ubiquitin
11%
Kinase
11%
Phosphotransferase
11%
Peptidase
11%
Expression Level
11%